Correction: Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy.
J Exp Clin Cancer Res
; 42(1): 135, 2023 May 30.
Article
in En
| MEDLINE
| ID: mdl-37248519
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Exp Clin Cancer Res
Year:
2023
Document type:
Article
Affiliation country:
Suecia